by Osel | Feb 16, 2018 | Featured, LACTIN-V, LACTIN-V CLINICAL
A new article in Genetic Engineering and Biotechnology News (GEN) explores the role of a woman’s vaginal microbiome in infertility. The story features our collaborators in Denmark who have launched a study to determine if Lactin-V could be used to restore a more...
by Osel | Feb 3, 2018 | Featured, LACTIN-V
Subtle changes to the microbiome in the vagina of pregnant women have been tied to pre-term labor in a recent study carried out by the Imperial College London. The study, published in the journal BMC Medicine, highlights the importance of the role of Lactobacillus...
by Osel | Jan 23, 2018 | announcements, Featured, LACTIN-V, MUCOCEPT
It’s the most common vaginal infection you’ve probably never heard of: Bacterial vaginosis (BV). It’s the culprit that causes embarrassing odors and discharge, and the reason many women visit their gynecologist. Nearly one-third of U.S. women of reproductive age have...
by Osel | Jan 17, 2018 | announcements
LACTIN-V Enters Clinical Study to Improve the Success Rate of IVF in Women with Imbalanced Vaginal Microbiomes Study based on findings that women with abnormal vaginal microbiota had only 9% success of pregnancy with IVF versus 44% for those with healthy vaginal...
by Osel | Jan 19, 2017 | announcements, Featured
Osel was featured in a recent article in Nature Medicine, “Living therapeutics: Scientist genetically modify bacteria to deliver drugs,” by Amy Maxmen. The article profiles our Director of Research Laurel Lagenaur and her work at Osel to investigate ways...
